On July 16, Cellavision AB will report earnings from the last quarter. Wall Street analysts expect Cellavision AB will be reporting earnings per share of SEK 1.13. Follow Cellavision AB stock price in ...

This information was released for public disclosure on January 27, 2017 at 08.20 am CET. CellaVision AB (public) today announced that its Nomination Committee proposes re-election of Sören Mellstig as ...

On October 22, Cellavision AB presents Q3 figures. Wall Street predict expect Cellavision AB will release earnings per share of SEK 1.08. Track Cellavision AB stock price in real-time on Markets ...

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy ...

CellaVision AB ((SE:CEVI)) has held its Q3 earnings call. Read on for the main highlights of the call. CellaVision AB’s recent earnings call painted a mixed picture, highlighting both strategic ...

An important question for mid-cap investors right now is how the ongoing uncertainty about the recovery in the broader economy will affect the share prices of companies like CellaVision AB.

Revenue: SEK179 million, up from SEK168 million last year. Organic Growth: 9% for the quarter. Gross Margin: Increased from 66% to 68%. EBITDA: SEK49 million, equivalent to 27% margin. R&D Expenses: ...

CellaVision AB (CLVSF) achieved all-time high sales in the APAC region, demonstrating strong regional performance. The company reported a strong gross margin of 69%, attributed to a favorable product ...

The third quarter of 2015 was a fantastic quarter for CellaVision, with historically strong growth in both sales and profitability. Sales increased by 58 percent compared with the same period in the ...

Sven-Åke Henningsson, member of CellaVision Board since 2006 and Chairman of the Audit Committee, has been appointed Acting CFO from September 1 until a permanent successor has been appointed.